EMEA-001211-PIP01-11-M02

Table of contents

Key facts

Active substance
Levofloxacin hemihydrate
Therapeutic area
Pneumology-allergology
Decision number
P/0511/2020
PIP number
EMEA-001211-PIP01-11-M02
Pharmaceutical form(s)
Nebuliser suspension
Condition(s) / indication(s)
Treatment of cystic fibrosis
Route(s) of administration
Inhalation use
Contact for public enquiries
Chiesi Farmaceutici S.p.A.

Tel. +39 0521 2791
E-mail: info@chiesi.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating